Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Fluorescence Imaging and AI in Cervical Cancer
NCT06840418Recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in Cervical Cancer (CC), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: Sensitivity of lymph node metastasis fluorescence imaging (Signal-to-Background Ratio). Started Jan 2025; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT06840418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06840418.